We partner with a secure submission system to handle manuscript submissions.
Please note:
You will need an account for the submission system, which is separate to your Cambridge Core account. For login and submission support, please visit the
submission and support pages.
Please review this journal's author instructions, particularly the
preparing your materials
page, before submitting your manuscript.
Click Proceed to submission system to continue to our partner's website.
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account.
Find out more about saving content to .
To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
We previously trained and tested a machine learning model to predict incident type 2 diabetes (T2D) in patients with mental illness using electronic health record (EHR) data from routine clinical practice. This hyperparameter-tuned XGBoost model – based on information on sex, age and mean HbA1c within the past two years – predicts whether a patient will meet criteria for T2D in the two years following each contact to psychiatric services. The performance of such a model may drift over time due to changes in standards of care, baseline risk, registration procedures, etc. Therefore, we set out to examine its temporal stability.
Methods:
In the present study, we fitted the model described above on EHR data from January 1, 2013 to December 31, 2017, and examined its stability in predicting T2D two years into the future for patients with contacts in 2018, 2019, 2020, 2021, 2022, and 2023, respectively. Performance was quantified using the area under the receiver operating characteristic curve (AUROC).
Results:
The model showed good discriminative performance across all years (AUROC for 2018 = 0.84, 2019 = 0.83, 2020 = 0.87, 2021 = 0.80, 2022 = 0.84, 2023 = 0.80), with a linear model estimating a decrease in AUROC for T2D prediction of only 0.004 per year (95%CI: –0.024; 0.016). Secondary analyses suggested that models trained on recent data (past year) may achieve similar or better discrimination than models trained on longer historical periods.
Conclusions:
The temporal stability of the T2D prediction model supports its potential for clinical implementation, facilitating early detection and tailored interventions, while highlighting the importance of continued evaluation.